Nexalin Technology, Inc. (NXL) Form 8-K — Aug 17, 2026
On August 14, 2026, Nexalin Technology received a Nasdaq Staff letter stating that, based on stockholders' equity of $1,519,423 reported in its 10-Q for the period ended June 30, 2026, the company no longer satisfies the $2,500,000 minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market under Rule 5550(b)(1). This is the company's second active listing deficiency. On July 24, 2026, Nexalin disclosed a Staff Determination for failing the minimum bid price requirement, and it is ineligible for an additional compliance period because it does not meet the $5,000,000 equity threshold required for initial listing.
Key figures
- Deficiencies
- ["Stockholders' Equity Deficiency (Rule 5550(b)(1))","Bid Price Deficiency (Rule 5550(a)(2))"]
- Nasdaq hearing date
- 2026-09-01
- Stockholders equity june 30 2026
- $1,519,423
- Minimum stockholders equity requirement
- $2,500,000
- Equity threshold for bid price compliance period
- $5,000,000
Price after filing
Close on the filing date to close N calendar days later (from $10.20). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.